According to an international team of researchers led by University College London and King’s College London, the discovery of a ‘molecular switch’ that causes the mucosal inflammatory diseases ulcerative colitis, Crohn’s disease, and celiac disease, could lead to effective new treatments for these autoimmune conditions. The discovery is reported in the journal PLoS Genetics. According to Soderquest et al, T-bet plays an important role in...